Edwards Lifesciences reported $402.4M in Operating Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbott ABT:US USD 1.33B 442M
Atricure ATRC:US USD -10723000 2.94M
Baxter International BAX:US USD -2799000000 3.15B
Becton, Dickinson and BDX:US USD 490M 45M
Boston Scientific BSX:US USD 358M 65M
Cardiovascular Systems CSII:US USD -10902000 1.42M
Cooper Companies COO:US USD 103.5M 37.1M
Cryolife CRY:US USD -4106000 8.65M
Dexcom DXCM:US USD 147.5M 70.5M
Edwards Lifesciences EW:US USD 402.4M 57.1M
Hologic HOLX:US USD 140.9M 123M
Icu Medical ICUI:US USD -467000 419K
Insulet PODD:US USD 2.9M 29.6M
Integra Lifesciences IART:US USD 63.73M 2.67M
Intuitive Surgical ISRG:US USD 372.5M 26.4M
Johnson & Johnson JNJ:US USD 4.2B 1.62B
Masimo MASI:US USD 54.8M 32.7M
Medtronic MDT:US USD 1.4B 339M
Merit Medical Systems MMSI:US USD 18.66M 4.6M
Nuvasive NUVA:US USD 21.77M 11.3M
Stryker SYK:US USD 808M 36M
Tandem Diabetes Care TNDM:US USD -47493000 35.25M
Teleflex TFX:US USD 132.44M 2.71M
Zimmer Biomet Holdings Inc ZBH:US USD 245.3M 35.6M